**Editor’s note: This is blog number two of six from NAMRU-6 on their vast research efforts.
Infectious bacteria have been causing problems for military campaigns since time immemorial. At the forefront has always been diarrhea, and with every deployment or armed conflict, diarrhea has taken its toll on unit readiness and the ability to operate at ones best. To counter this burden, the overseas medical research labs have been investigating and developing strategies to mitigate the detrimental effects of bacterial diarrhea over the last 30 years. Due to this effort, surveillance networks have been set up to help determine the most common causes of diarrhea within our troops and which bacteria are responsible for the most severe illness worldwide.
At NAMRU-6, we focused on diarrhea occurring within travelers to Peru, deployed troops as part of operations New Horizons and Beyond the Horizons, and within the local populations to get a pulse on which bacteria are causing diarrhea within South America and to determine if these bacteria are developing resistant to the antibiotics commonly used to treat these cases. This has become vital information in the development of countermeasures to keep our people healthy and to focus Department of Defense vaccine development efforts.
As part of our mission, we have been integrally involved in the pre-clinical trials of novel vaccines against some of the most common bacterial cause of travelers’ diarrhea. Vaccines against Campylobacter, enterotoxigenic Escherichia coli (ETEC), and Shigella are currently under development with the assistance of the Military Infectious Disease Research Program (MIDRP) and have the potential to provide needed protection against the morbidity associated with these common causes of diarrhea while deployed.
Another potential morbidity for deployed service members are wound infections. Wounds and hospital acquired infections have become more difficult to treat in recent years due to multi-drug resistant bacteria which are harder to kill with standard antibiotics. As shown with recent conflicts in South-West Asia, these bacteria have complicated hospital courses for our wounded service members and have proven to be a global health threat. Given this threat, NAMRU-6 is spearheading surveillance in South America for the presence of resistant organisms with the potential to cause severe hospital or wound infections. In concert with multiple military and civilian hospitals within the city of Lima, Peru and within the Amazon town of Iquitos, isolates known to cause hospital acquired infection and those associated with wound infections are collected and analyzed for the emergence of resistance and for virulence factors which make them more deadly. Through our efforts, we are beginning to fully grasp the scope of the problem and to develop strategies to counter this global health threat.
Although the Bacteriology Department at NAMRU-6 is only one department in one overseas lab, it is part of a bigger system whose strength is in its connectivity to the region and its ability to form channels of communication between institution and researchers with a common goal. Through this teamwork, progress toward mitigating and or eliminating infectious disease threats will remain progressive.
To read blog number one in the series from NAMRU-6 click here.